Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More
Isoxazolines in canine parasite control
May 29th 2025Kathryn E. Rief, MSPH, PhD, discusses how lotilaner’s systemic distribution and consistent efficacy throughout the dosing period make it a reliable option for targeting ticks, including the lone star tick, before pathogen transmission occurs.
Read More
Vet Watch Update: New World screwworm
May 16th 2025Amid a surge to more than 1400 confirmed New World screwworm cases in Mexico and an immediate US suspension of live cattle imports, Christopher Lee, DVM, MPH, DACVPM, warns this parasitic fly could breach the southern border by year’s end, posing serious risks to livestock, pets, wildlife, and even human health.
Read More
Vet Watch: Tips and pitfalls of dermatology in the new age of isoxazolines
Introducing Vet Watch! Christopher Lee, DVM, MPH, DACVPM, and Alice Jeromin, DVM, RPh, DACVD, discuss the clinical benefits and practical applications of isoxazoline parasiticides for year-round ectoparasite control.
Read More
Understanding the physiology behind SGLT2 inhibitors
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), describes a sodium-glucose cotransporter-2 inhibitor in a dvm360 interview.
Read More